KR100849979B1 - 2-데옥시-엘-리보오스의 제조방법 - Google Patents
2-데옥시-엘-리보오스의 제조방법 Download PDFInfo
- Publication number
- KR100849979B1 KR100849979B1 KR1020060122752A KR20060122752A KR100849979B1 KR 100849979 B1 KR100849979 B1 KR 100849979B1 KR 1020060122752 A KR1020060122752 A KR 1020060122752A KR 20060122752 A KR20060122752 A KR 20060122752A KR 100849979 B1 KR100849979 B1 KR 100849979B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- deoxy
- ribose
- prepare
- compound
- Prior art date
Links
- ASJSAQIRZKANQN-UHNVWZDZSA-N 2-deoxy-L-arabinose Chemical compound OC[C@H](O)[C@H](O)CC=O ASJSAQIRZKANQN-UHNVWZDZSA-N 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 50
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 48
- 238000000034 method Methods 0.000 claims abstract description 38
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 23
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 22
- 239000002904 solvent Substances 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 150000007530 organic bases Chemical class 0.000 claims abstract description 13
- UGJBHEZMOKVTIM-UHFFFAOYSA-N N-formylglycine Chemical compound OC(=O)CNC=O UGJBHEZMOKVTIM-UHFFFAOYSA-N 0.000 claims abstract description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000003377 acid catalyst Substances 0.000 claims abstract description 9
- 230000002378 acidificating effect Effects 0.000 claims abstract description 9
- 230000007062 hydrolysis Effects 0.000 claims abstract description 9
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 9
- 239000011701 zinc Substances 0.000 claims abstract description 9
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 9
- 150000001263 acyl chlorides Chemical class 0.000 claims abstract description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 36
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 28
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 23
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 18
- 125000005425 toluyl group Chemical group 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 14
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 14
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 230000002140 halogenating effect Effects 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical class 0.000 claims description 8
- 230000010933 acylation Effects 0.000 claims description 7
- 238000005917 acylation reaction Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims description 6
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 claims description 5
- -1 chlorobenzoyl Chemical group 0.000 claims description 5
- 238000006386 neutralization reaction Methods 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 4
- 229910052794 bromium Inorganic materials 0.000 claims 4
- 230000026030 halogenation Effects 0.000 claims 4
- 238000005658 halogenation reaction Methods 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000031709 bromination Effects 0.000 abstract 1
- 238000005893 bromination reaction Methods 0.000 abstract 1
- 150000003214 pyranose derivatives Chemical class 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 125000002252 acyl group Chemical group 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 7
- 239000012346 acetyl chloride Substances 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- 241001442129 Myosotis Species 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 150000007522 mineralic acids Chemical class 0.000 description 5
- 239000002777 nucleoside Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-MROZADKFSA-N aldehydo-L-ribose Chemical compound OC[C@H](O)[C@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-MROZADKFSA-N 0.000 description 2
- 125000005233 alkylalcohol group Chemical group 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 2
- YWBHROUQJYHSOR-UHFFFAOYSA-N $l^{1}-selanylbenzene Chemical compound [Se]C1=CC=CC=C1 YWBHROUQJYHSOR-UHFFFAOYSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-GJMOJQLCSA-N 1-[(2r,4r,5s)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@@H](CO)[C@H](O)C1 IQFYYKKMVGJFEH-GJMOJQLCSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- BUBVLQDEIIUIQG-UHFFFAOYSA-N 3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-one Chemical compound C=1C=CC=CC=1COC1C(OCC=2C=CC=CC=2)C(OCC=2C=CC=CC=2)C(=O)OC1COCC1=CC=CC=C1 BUBVLQDEIIUIQG-UHFFFAOYSA-N 0.000 description 1
- 0 C*C(COCC1)C1O Chemical compound C*C(COCC1)C1O 0.000 description 1
- KDUCYGOVYIGXND-UHFFFAOYSA-N CC(COCC1)C1O Chemical compound CC(COCC1)C1O KDUCYGOVYIGXND-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- WREGKURFCTUGRC-POYBYMJQSA-N Zalcitabine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)CC1 WREGKURFCTUGRC-POYBYMJQSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- CDSGJHCARATGKG-UHFFFAOYSA-N bis(3-methylbutyl)borane Chemical compound CC(C)CCBCCC(C)C CDSGJHCARATGKG-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005311 telbivudine Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/08—Deoxysugars; Unsaturated sugars; Osones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (19)
- 하기 식 (1)의 L-아라비노오스를 아실화 및 할로겐화시켜 하기 식 (5)의 1-할로-2,3,4-트리아실화합물을 제조하고; 에틸 아세테이트와 유기염기 존재하에 아연과 반응시켜 하기 식 (6)의 글리칼을 제조한 후; 산 조건하에 알코올 용매로 처리하여 하기 식 (7)의 1-알콕시-2-데옥시-3,4-디아실-L-리보피라노오스를 제조하고; 염기로 처리하여 하기 식 (8)의 1-알콕시-2-데옥시-L-리보피라노오스를 제조한 후; 산 촉매하에 가수분해하는 것으로 구성되는 하기 식 I의 2-데옥시-L-리보오스의 제조방법:(1)(5)(6)(7)(8)I상기 식에서 R1은 C1~C5의 저급알킬기이고, R2', R3', R4'는 벤조일 또는 톨루일이고 , Hal는 할로겐이다.
- 제 1 항에 있어서, 상기 식 (1)의 L-아라비노오스를 아실화 및 할로겐화시켜 상기 식 (5)의 1-할로-2,3,4-트리아실화합물을 제조하는 단계는 상기 식(1)의 L-아라비노오스를 산 조건하에 알코올 용매로 처리하여 하기 식 (2)의 1-알콕시-L-아라비노피라노오스를 제조한 후; 아실화하여 하기 식 (3)의 1-알콕시-2,3,4-트리아실-L-아라비노피라노오스를 제조하고; 할로겐화하여 상기 식 (5)의 1-할로-2,3,4-트리아실화합물을 얻는 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.(2)(3)상기 식에서 R1은 C1~C5의 저급알킬기이고, R2', R3', R4'는 벤조일 또는 톨루일이다.
- 제 1 항 또는 제 2 항에 있어서, R1은 은 C3∼C4의 저급알킬기이며 R2', R3', R4'는 벤조일이고, 톨루일 또는 클로로벤조일이고, Hal는 브롬인 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 3 항에 있어서, R1', R2', R3', R4'는 벤조일이고, 톨루일 또는 클로로벤조일이고, Hal는 브롬인 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 2 항 또는 제 3 항에 있어서, 아실화는 피리딘 용매에서 아실클로라이드와 반응시켜 행하는 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 2 항 또는 제 3 항에 있어서, 할로겐화는 브롬화수소를 사용하여 행하는 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 1 항에 있어서, 상기 글리칼 제조에 사용되는 유기 염기는 N-메틸이미다졸, 피리딘, 또는 트리에틸아민 또는 이들의 혼합물인 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 1 항에 있어서, 상기 식 (7)의 1-알콕시-2-데옥시-3,4-디아실-L-리보피라노오스의 처리에 사용되는 염기는 수산화나트륨 또는 소디움 메톡사이드인 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 1 항에 있어서, 상기 가수 분해에 사용되는 산 촉매는 묽은 황산, 묽은 염산, 또는 묽은 초산이고 가수분해는 40℃에서 행해지는 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법
- 제 11 항에 있어서, 상기 식 (1)의 L-아라비노오스를 아실화 및 할로겐화시켜 상기 식 (5)의 1-할로-2,3,4-트리아실화합물을 제조하는 단계는 상기 식(1)의 L-아라비노오스를 산 조건하에 알코올 용매로 처리하여 하기 식 (2)의 1-알콕시-L-아라비노피라노오스를 제조한 후; 아실화하여 하기 식 (3)의 1-알콕시-2,3,4-트리아실-L-아라비노피라노오스를 제조하고; 할로겐화하여 상기 식 (5)의 1-할로-2,3,4-트리아실화합물을 얻는 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.(2)(3)상기 식에서 R1은 C1~C5의 저급알킬기이고, R2', R3', R4'는 벤조일 또는 톨루일이다.
- 제 11 항 또는 제 12 항에 있어서, R1은 프로필기이며 R2', R3', R4'는 벤조일이고, Hal는 브롬인 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 13 항에 있어서, R1', R2', R3', R4'는 벤조일이고, 클로로벤조일 또는 톨루일이고, Hal는 브롬인 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 12 항 또는 제 13 항에 있어서, 아실화는 피리딘 용매에서 아실클로라이드와 반응시켜 행하는 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 12 항 또는 제 13 항에 있어서, 할로겐화는 브롬화수소를 사용하여 행하는 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 11 항에 있어서, 상기 글리칼 제조에 사용되는 유기 염기는 N-메틸이미다졸, 피리딘, 또는 트리에틸아민 또는 이들의 혼합물인 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법.
- 제 11 항에 있어서, 상기 가수 분해에 사용되는 산 촉매는 묽은 황산, 묽은 염산, 또는 묽은 초산이고 가수분해는 0℃에서 행해지는 것을 특징으로 하는 2-데옥시-L-리보오스의 제조방법
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060122752A KR100849979B1 (ko) | 2006-12-06 | 2006-12-06 | 2-데옥시-엘-리보오스의 제조방법 |
PCT/KR2007/005244 WO2008069440A1 (en) | 2006-12-06 | 2007-10-24 | The preparation method of 2-de0xy-l-rib0se |
GB0910201A GB2456999B (en) | 2006-12-06 | 2007-10-24 | Method for preparing 2-deoxy-L-ribose |
US12/312,889 US8114987B2 (en) | 2006-12-06 | 2007-10-24 | Preparation method of 2-deoxy-L-ribose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060122752A KR100849979B1 (ko) | 2006-12-06 | 2006-12-06 | 2-데옥시-엘-리보오스의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080051502A KR20080051502A (ko) | 2008-06-11 |
KR100849979B1 true KR100849979B1 (ko) | 2008-08-01 |
Family
ID=39492272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060122752A KR100849979B1 (ko) | 2006-12-06 | 2006-12-06 | 2-데옥시-엘-리보오스의 제조방법 |
Country Status (4)
Country | Link |
---|---|
US (1) | US8114987B2 (ko) |
KR (1) | KR100849979B1 (ko) |
GB (1) | GB2456999B (ko) |
WO (1) | WO2008069440A1 (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL2007240C2 (en) * | 2011-08-09 | 2013-02-12 | Konink Co Peratie Cosun U A | Sugar-based plasticizers. |
CN102643257B (zh) * | 2012-04-25 | 2014-04-16 | 济南圣泉唐和唐生物科技有限公司 | 一种烯糖的制备方法 |
CN102702276B (zh) * | 2012-06-08 | 2015-07-08 | 济南圣泉唐和唐生物科技有限公司 | 一种烯糖反应液的后处理方法 |
CN102936270B (zh) * | 2012-11-28 | 2015-04-22 | 济南圣泉唐和唐生物科技有限公司 | 一种烯糖与醇类化合物的加成方法 |
CN103694279B (zh) * | 2013-12-23 | 2015-12-02 | 江西苏克尔新材料有限公司 | 一种制备2-脱氧-l-核糖的方法 |
CN105330704B (zh) * | 2015-11-13 | 2019-05-10 | 天津现代职业技术学院 | 2-脱氧-d-葡萄糖的制备方法 |
CN105732732B (zh) * | 2016-04-14 | 2018-04-06 | 四川理工学院 | 一种制备2‑脱氧‑d‑核糖的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998031697A1 (en) | 1997-01-15 | 1998-07-23 | Sankyo Company, Limited | Aryl c-glycoside compounds and sulfated esters thereof |
WO1999061583A2 (en) | 1998-05-28 | 1999-12-02 | Incara Pharmaceuticals Corp. | Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction |
WO2001014395A2 (en) | 1999-08-20 | 2001-03-01 | Sloan-Kettering Institute For Cancer Research | Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
JP2001172250A (ja) * | 1999-12-14 | 2001-06-26 | Ono Pharmaceut Co Ltd | グルコピラノース誘導体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6686698A (en) | 1997-03-05 | 1998-09-22 | Regents Of The University Of California, The | Synthesis of l-ribose and 2-deoxy l-ribose |
KR100433179B1 (ko) | 2001-11-10 | 2004-05-27 | 주식회사 삼천리제약 | 2-데옥시-l-리보오스의 제조방법 |
KR100446560B1 (ko) | 2002-07-15 | 2004-09-04 | 주식회사 삼천리제약 | 2-데옥시-l-리보오스의 제조방법 |
US20060266147A1 (en) | 2005-05-27 | 2006-11-30 | Bowen Thomas C | Shifter assembly for manual transmission |
-
2006
- 2006-12-06 KR KR1020060122752A patent/KR100849979B1/ko active IP Right Grant
-
2007
- 2007-10-24 WO PCT/KR2007/005244 patent/WO2008069440A1/en active Application Filing
- 2007-10-24 US US12/312,889 patent/US8114987B2/en not_active Expired - Fee Related
- 2007-10-24 GB GB0910201A patent/GB2456999B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998031697A1 (en) | 1997-01-15 | 1998-07-23 | Sankyo Company, Limited | Aryl c-glycoside compounds and sulfated esters thereof |
WO1999061583A2 (en) | 1998-05-28 | 1999-12-02 | Incara Pharmaceuticals Corp. | Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction |
WO2001014395A2 (en) | 1999-08-20 | 2001-03-01 | Sloan-Kettering Institute For Cancer Research | Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
JP2001172250A (ja) * | 1999-12-14 | 2001-06-26 | Ono Pharmaceut Co Ltd | グルコピラノース誘導体 |
Also Published As
Publication number | Publication date |
---|---|
GB2456999A (en) | 2009-08-05 |
GB0910201D0 (en) | 2009-07-29 |
US8114987B2 (en) | 2012-02-14 |
GB2456999B (en) | 2011-04-27 |
KR20080051502A (ko) | 2008-06-11 |
US20090292117A1 (en) | 2009-11-26 |
WO2008069440A1 (en) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100849979B1 (ko) | 2-데옥시-엘-리보오스의 제조방법 | |
JP2010505954A5 (ko) | ||
KR20150018524A (ko) | 2-데옥시-2-플루오로-2-메틸-d-리보푸라노실 뉴클레오시드 화합물의 제조 방법 | |
JP2001515086A5 (ko) | ||
FI105402B (fi) | Menetelmä 2',3'-didehydro-2',3'-dideoksinukleosidien laajamittaista valmistusta varten | |
JP5700910B2 (ja) | 置換アニシジンの調製方法 | |
JP3677790B2 (ja) | ヌクレオシド誘導体とその製造方法 | |
JP4892472B2 (ja) | 5−クロロ−2,4−ジヒドロキシピリジンの製造方法 | |
JP2009526782A (ja) | ゲムシタビンおよび関連中間体の製造方法 | |
JPH11228540A (ja) | 2−(4−ピリジル)エタンチオールの製造方法 | |
KR100393913B1 (ko) | 5-메틸우리딘으로부터디4티를제조하는방법 | |
KR100446560B1 (ko) | 2-데옥시-l-리보오스의 제조방법 | |
KR102670551B1 (ko) | 6-플루오로-3-하이드록시피라진-2-카르복사마이드의 제조방법 ( | |
CN111100071A (zh) | 一种合成2-氰基-5-芳基-1h-咪唑类化合物的方法 | |
JP2666160B2 (ja) | 5−o−ピリミジル−2,3−ジデオキシ−1−チオフラノシド誘導体,その製造方法及び用途 | |
KR100433179B1 (ko) | 2-데옥시-l-리보오스의 제조방법 | |
AU2004296242A1 (en) | Improved synthesis of 2-substituted adenosines | |
KR100639705B1 (ko) | 1-메톡시-2-데옥시-엘-리보스의 제조방법 | |
JPWO2010079813A1 (ja) | イノシン誘導体の製造方法 | |
JPH0899990A (ja) | アジド化ヌクレオシド誘導体の製造方法 | |
JPH06135962A (ja) | 2’,3’−ジデオキシヌクレオシド誘導体の製造方法 | |
JPH07116210B2 (ja) | チミン誘導体 | |
JPH0416472B2 (ko) | ||
JP2006265156A (ja) | 2−デオキシ−l−リボフラノシルクロリド化合物の製造方法 | |
JPH11255725A (ja) | 2−アミノフェネチルアルコール誘導体の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120626 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130708 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140728 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150728 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160708 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170719 Year of fee payment: 10 |